These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 2921499

  • 1. Low-dose ursodeoxycholic acid prolongs cholesterol nucleation time in gallbladder bile of patients with cholesterol gallstones.
    Jüngst D, Brenner G, Pratschke E, Paumgartner G.
    J Hepatol; 1989 Jan; 8(1):1-6. PubMed ID: 2921499
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Activity of cholesterol in human gallbladder bile in relation to nucleation of cholesterol monohydrate crystals.
    Noshiro H, Chijiiwa K, Hirota I.
    Clin Chim Acta; 1992 Feb 14; 205(3):167-79. PubMed ID: 1576744
    [Abstract] [Full Text] [Related]

  • 6. Effect of litholytic bile acids on cholesterol absorption in gallstone patients.
    LaRusso NF, Thistle JL.
    Gastroenterology; 1983 Feb 14; 84(2):265-71. PubMed ID: 6848406
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Biliary lipid composition in patients with cholesterol and pigment gallstones and gallstone-free subjects: deoxycholic acid does not contribute to formation of cholesterol gallstones.
    Gustafsson U, Sahlin S, Einarsson C.
    Eur J Clin Invest; 2000 Dec 14; 30(12):1099-106. PubMed ID: 11122325
    [Abstract] [Full Text] [Related]

  • 9. Effects of ursodeoxycholic acid and aspirin on the formation of lithogenic bile and gallstones during loss of weight.
    Broomfield PH, Chopra R, Sheinbaum RC, Bonorris GG, Silverman A, Schoenfield LJ, Marks JW.
    N Engl J Med; 1988 Dec 15; 319(24):1567-72. PubMed ID: 3200265
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Deoxycholic acid influences cholesterol solubilization and microcrystal nucleation time in gallbladder bile.
    Hussaini SH, Pereira SP, Murphy GM, Dowling RH.
    Hepatology; 1995 Dec 15; 22(6):1735-44. PubMed ID: 7489982
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Ursodeoxycholic acid treatment in cholesterol gallstone disease: effects on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity, biliary lipid composition, and plasma lipid levels.
    Angelin B, Ewerth S, Einarsson K.
    J Lipid Res; 1983 Apr 15; 24(4):461-8. PubMed ID: 6854153
    [Abstract] [Full Text] [Related]

  • 14. Effect of ursodeoxycholic acid administration on nucleation time in human gallbladder bile.
    Tazuma S, Sasaki H, Mizuno S, Sagawa H, Hashiba S, Horiuchi I, Kajiyama G.
    Gastroenterology; 1989 Jul 15; 97(1):173-8. PubMed ID: 2498145
    [Abstract] [Full Text] [Related]

  • 15. Gallstone dissolution treatment with a combination of chenodeoxycholic and ursodeoxycholic acids. Studies of safety, efficacy and effects on bile lithogenicity, bile acid pool, and serum lipids.
    Roehrkasse R, Fromm H, Malavolti M, Tunuguntla AK, Ceryak S.
    Dig Dis Sci; 1986 Oct 15; 31(10):1032-40. PubMed ID: 3757719
    [Abstract] [Full Text] [Related]

  • 16. The effect of ursodeoxycholic acid on nucleation time in patients with solitary or multiple gallbladder stones.
    Tudyka J, Wechsler JG, Mason R, Maier C.
    Am J Gastroenterol; 1994 Aug 15; 89(8):1206-10. PubMed ID: 8053436
    [Abstract] [Full Text] [Related]

  • 17. Utility of biliary microscopy for the prediction of the chemical composition of gallstones and the outcome of dissolution therapy with ursodeoxycholic acid.
    Ros E, Navarro S, Fernández I, Reixach M, Ribó JM, Rodés J.
    Gastroenterology; 1986 Sep 15; 91(3):703-12. PubMed ID: 3732768
    [Abstract] [Full Text] [Related]

  • 18. A combination of chenodeoxycholic acid and ursodeoxycholic acid is more effective than either alone in reducing biliary cholesterol saturation.
    Podda M, Zuin M, Dioguardi ML, Festorazzi S, Dioguardi N.
    Hepatology; 1982 Sep 15; 2(3):334-9. PubMed ID: 7076116
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.